(Reuters) -Telehealth firm Hims & Hers Health said on Tuesday it plans to sell Eli Lilly's diabetes and weight-loss drugs on ...

Shares of Hims & Hers Health (NYSE: HIMS) surged on Tuesday, closing the session up 5.25% after having been up by as much as ...

The company’s stock rise reflects investor optimism following the news that Hims & Hers will provide both branded versions of ...

Hims & Hers Health Inc (NYSE:HIMS) shares spiked higher in afternoon trading Tuesday after the company said it will offer Eli ...

Here are five key ways cloud computing is revolutionising the healthcare industry, along with insights into how a few ...

That will prompt a call-back on their device from a physician or other healthcare professional within Teladoc's network, and in some cases users will also be able to received prescribed medicines ...

Hims shares gained as much as 14% in New York, their biggest gain since Feb. 19.

Silicon Valley Trump supporter and Andreessen Horowitz's co-founder, Marc Andreessen, is in talks to add new outside ...